These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2319472)
1. Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. Austin MC; Kalivas PW J Pharmacol Exp Ther; 1990 Mar; 252(3):1370-7. PubMed ID: 2319472 [TBL] [Abstract][Full Text] [Related]
2. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. Latimer LG; Duffy P; Kalivas PW J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus. Klitenick MA; Kalivas PW J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850 [TBL] [Abstract][Full Text] [Related]
4. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats. Noel MB; Gratton A Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Austin MC; Kalivas PW Brain Res; 1991 Feb; 542(1):123-31. PubMed ID: 2054650 [TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area. Klitenick MA; Wirtshafter D J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785 [TBL] [Abstract][Full Text] [Related]
7. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Austin MC; Kalivas PW Jpn J Pharmacol; 1989 Aug; 50(4):487-90. PubMed ID: 2779013 [TBL] [Abstract][Full Text] [Related]
8. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. Mitrovic I; Napier TC J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342 [TBL] [Abstract][Full Text] [Related]
9. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
10. Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Churchill L; Austin MC; Kalivas PW Psychopharmacology (Berl); 1992; 108(1-2):141-6. PubMed ID: 1410135 [TBL] [Abstract][Full Text] [Related]
11. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. Hooks MS; Kalivas PW J Pharmacol Exp Ther; 1994 Jun; 269(3):976-88. PubMed ID: 7516970 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. Johnson K; Churchill L; Klitenick MA; Hooks MS; Kalivas PW J Pharmacol Exp Ther; 1996 May; 277(2):1122-31. PubMed ID: 8627524 [TBL] [Abstract][Full Text] [Related]
13. Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity. Churchill L; Klitenick MA; Kalivas PW J Neurosci; 1998 Oct; 18(19):8074-85. PubMed ID: 9742174 [TBL] [Abstract][Full Text] [Related]
14. Neurochemical modulation of ingestive behavior in the ventral pallidum. Shimura T; Imaoka H; Yamamoto T Eur J Neurosci; 2006 Mar; 23(6):1596-604. PubMed ID: 16553623 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of mu opioid-induced motor activity in the ventral pallidum by D1 receptor blockade. Alesdatter JE; Kalivas PW Behav Pharmacol; 1993 Dec; 4(6):645-651. PubMed ID: 11224233 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. Hammond DL; Wang H; Nakashima N; Basbaum AI J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201 [TBL] [Abstract][Full Text] [Related]
17. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. Kalivas PW; Duffy P; Eberhardt H J Pharmacol Exp Ther; 1990 May; 253(2):858-66. PubMed ID: 2160011 [TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats. Locke KW; Holtzman SG J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231 [TBL] [Abstract][Full Text] [Related]
19. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides. Kiritsy-Roy JA; Marson L; Van Loon GR J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411 [TBL] [Abstract][Full Text] [Related]
20. Switching to cue-directed behavior: specific for ventral striatal dopamine but not ventral pallidum/substantia innominata gaba as revealed by a swimming-test procedure in rats. van den Bos R; Cools AR Neuroscience; 2003; 118(4):1141-9. PubMed ID: 12732257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]